Identification of novel glutathione conjugates of terbinafine in liver microsomes and hepatocytes across species

References

• Abdel-Rahman SM, Nahata MC. (1997). Oral terbinafine: a new antifungal agent. Ann Pharmacother 31:445–56.
   PubMed Web of Science ®Google Scholar
• Ajit C, Zaeri N, Munoz SJ, Suvannasankha A. (2003). Terbinafine-associated hepatotoxicity. Am J Med Sci 325:292–5.
   PubMed Web of Science ®Google Scholar
• Amichai B, Grunwald MH. (1998). Adverse drug reactions of the new oral antifungal agents-terbinafine, fluconazole, and itraconazole. Int J Dermatol 37:410–5.
   PubMed Web of Science ®Google Scholar
• Amitay-Layish I, Feuerman H, David M. (2006). Subacute cutaneous lupus erythematosus induced by terbinafine. Harefuah 145:480–2.
   PubMedGoogle Scholar
• Balfour JA, Faulds D. (1992). Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 43:259–84.
   PubMed Web of Science ®Google Scholar
• Bialecki J, Ruzicka J, Attygalle AB. (2006). An unprecedented rearrangement in collision-induced mass spectrometric fragmentation of protonated benzylamines. J Mass Spectrom 41:1195–204.
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Castagnoli N, Nelson S, et al. (1987). Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. Drug Metab Dispos 15:491–8.
   PubMed Web of Science ®Google Scholar
• Carstens J, Wendelboe P, Søgaard H, Thestrup-Pedersen K. (1994). Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol 74:391–2.
   PubMed Web of Science ®Google Scholar
• Fernandes NF, Geller SA, Fong T-L. (1998). Terbinafine hepatotoxicity: case report and review of the literature. Am J Gastroenterol 93:459.
   PubMed Web of Science ®Google Scholar
• Gadberry MG, DeNicola DB, Carlson GP. (1996). Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. J Toxicol Environ Health 48:273–94.
   PubMed Web of Science ®Google Scholar
• Gray AL, Wirtz VJ, 't Hoen EFM, et al. (2015). Essential medicines are still essential. Lancet 386:1601–3.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Soori GS, Del Rosso JQ, et al. (1998). Severe neutropenia associated with oral terbinafine therapy. J Am Acad Dermatol 38:765–7.
   PubMed Web of Science ®Google Scholar
• Hosseini-Yeganeh M, McLachlan AJ. (2002). Physiologically based pharmacokinetic model for terbinafine in rats and humans. Antimicrob Agents Chemother 46:2219–28.
   PubMed Web of Science ®Google Scholar
• Humbert H, Denouel J, Cabiac M, et al. (1998). Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration. Biopharm Drug Dispos 19:417–23.
   PubMed Web of Science ®Google Scholar
• Iverson SL, Uetrecht JP. (2001). Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity. Chem Res Toxicol 14:175–81.
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Gardner I, Obach RS, et al. (2005). A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225.
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS. 2011. Metabolic Activation of Organic Functional Groups Utilized in Medicinal Chemistry. In: Lee, MS, Zhu, M. eds. Mass Spectrometry in Drug Metabolism and Disposition: Basic Principles and Applications. Hoboken, NJ: John Wiley & Sons. 43–82.
   Google Scholar
• Kamble SH, Sharma A, King TI, et al. (2018). Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom). Xenobiotica 1. doi: 10.1080/00498254.2018.1552819
   PubMed Web of Science ®Google Scholar
• Khoza S, Moyo I, Ncube D. (2017). Comparative hepatotoxicity of fluconazole, ketoconazole, itraconazole, terbinafine, and griseofulvin in rats. J Toxicol 2017:1–9.
   PubMedGoogle Scholar
• Kovarik JM, Mueller EA, Zehender H, et al. (1995). Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob Agents Chemother 39:2738–41.
   PubMed Web of Science ®Google Scholar
• Maggs JL, Naisbitt DJ, Tettey JN, et al. (2000). Metabolism of lamotrigine to a reactive arene oxide intermediate. Chem Res Toxicol 13:1075–81.
   PubMed Web of Science ®Google Scholar
• Moseley R. (2007). Antibacterial and antifungal agents. Drug-induced liver disease, 2nd ed. USA, New York: Informa Healthcare.
   Google Scholar
• Nowosielski M, Hoffmann M, Wyrwicz LS, et al. (2011). Detailed mechanism of squalene epoxidase inhibition by terbinafine. J Chem Inf Model 51:455–62.
   PubMed Web of Science ®Google Scholar
• Perveze Z, Johnson MW, Rubin RA, et al. (2007). Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transplant 13:162–4.
   PubMed Web of Science ®Google Scholar
• Stepan AF, Walker DP, Bauman J, et al. (2011). Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24:1345–410.
   PubMed Web of Science ®Google Scholar
• Stricker B, Van Riemsdijk M, Sturkenboom M, Ottervanger J. (1996). Taste loss to terbinafine: a case-control study of potential risk factors . Br J Clin Pharmacol 42:313–8.
   PubMed Web of Science ®Google Scholar
• Subramanian M, Kurawattimath V, Pocha K, et al. (2014). Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese rats. Xenobiotica 44:1108–16.
   PubMed Web of Science ®Google Scholar
• Terrab Z, El TO, Zouhair K, et al. (2006). Terbinafine-induced Stevens-Johnson syndrome and aggravation of systemic lupus erythematosus. Annales de dermatologie et de Venereologie 133:463–6.
   PubMedGoogle Scholar
• Vickers AE, Sinclair JR, Zollinger M, et al. (1999). Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. Drug Metab Dispos 27:1029–38.
   PubMed Web of Science ®Google Scholar
• Wen B, Ma L, Zhu M. (2008). Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s. Chem Biol Interact 173:59–67.
   PubMed Web of Science ®Google Scholar
• Wolkenstein P, Tan C, Lecoeur S, et al. (1998). Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem Biol Interact 113:39–50.
   PubMed Web of Science ®Google Scholar
• Wu G, Vashishtha SC, Erve JC. (2010). Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. Chem Res Toxicol 23:1393–404.
   PubMed Web of Science ®Google Scholar